Art

J-GLOBAL ID：201802280781806323   Reference number：18A1014198

Periprocedural Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation Without Discontinuation of a Vitamin K Antagonist and Direct Oral Anticoagulants

ビタミンK拮抗薬と直接作用型経口抗凝固剤を中止せずに心房細動のカテーテルアブレーションを受けている患者における周術期合併症

Author (14)： Kojima Toshiya (Department of Cardiovascular Medicine, The University of Tokyo) ,  Fujiu Katsuhito (Department of Cardiovascular Medicine, The University of Tokyo) ,  Fujiu Katsuhito (Department of Ubiquitous Health Informatics, The University of Tokyo) ,  Fukuma Nobuaki (Department of Cardiovascular Medicine, The University of Tokyo) ,  Matsunaga Hiroshi (Department of Cardiovascular Medicine, The University of Tokyo) ,  Oshima Tsukasa (Department of Cardiovascular Medicine, The University of Tokyo) ,  Matsuda Jun (Department of Cardiovascular Medicine, The University of Tokyo) ,  Matsubara Takumi (Department of Cardiovascular Medicine, The University of Tokyo) ,  Shimizu Yu (Department of Cardiovascular Medicine, The University of Tokyo) ,  Oguri Gaku (Department of Cardiovascular Medicine, The University of Tokyo) ,  Oguri Gaku (Clinical Research Support Center, The University of Tokyo) ,  Hasumi Eriko (Department of Cardiovascular Medicine, The University of Tokyo) ,  Morita Hiroyuki (Department of Cardiovascular Medicine, The University of Tokyo) ,  Komuro Issei (Department of Cardiovascular Medicine, The University of Tokyo)
Material： Circulation Journal  (Circ J)
Volume： 82  Issue： 6  Page： 1552-1557(J-STAGE)  Publication year： 2018 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *auricular fibrillation ,...
Semi thesaurus term： *vitamin K antagonist ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1014198&from=J-GLOBAL&jstjournalNo=F0908A") }}

Author keywords (3)： Ablation ,  Anticoagulants ,  Atrial fibrillation

JST classification (1)： Treatment for cardiovasular system diseases in general  (GJ05010B)

Reference (20)：

• 1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606.
• 2. Di Biase L, Burkhardt JD, Santangeli P, Mohanty P, Sanchez JE, Horton R, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: Results from the role of coumadin in preventing thromboembolism in atrial fibrillation (AF) patients undergoing catheter ablation (COMPARE) randomized trial. Circulation 2014; 129: 2638-2644.
• 3. Page SP, Siddiqui MS, Finlay M, Hunter RJ, Abrams DJ, Dhinoja M, et al. Catheter ablation for atrial fibrillation on uninterrupted warfarin: Can it be done without echo guidance? J Cardiovasc Electrophysiol 2011; 22: 265-270.
• 4. Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, et al. Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation. N Engl J Med 2017; 376: 1627-1636.
• 5. Lakkireddy D, Reddy YM, Di Biase L, Vallakati A, Mansour MC, Santangeli P, et al. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: Results from a multicenter prospective registry. J Am Coll Cardiol 2014; 63: 982-988.

Terms in the title (7)： ビタミンK拮抗薬 ,  経口抗凝固剤 ,  中止 ,  心房細動 ,  カテーテルアブレーション ,  患者 ,  周術期合併症